SavedAdd your journal

Journals / Southern Clinics of Istanbul Eurasia / 2018 / Cilt: 29 - Sayı: 3

Efficient Treatment of Resistant Orbital Pseudotumor with CyberKnife: Case Series and Short Review of Literature

Dirençli Orbital Psödo Tümörün CyberKnife Etkin Tedavisi: Olgu Serisi ve Literatürün Kısa Gözden Geçirilmesi

Naciye IŞIK
Dilber ÇELİK YAPRAK
Gökhan YAPRAK
Ahmet Kasım KILIÇ
Özgür Ozan ŞEŞEOĞULLAR
Pages
198–202
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presently described are 3 cases of orbital pseudotumorthat had a partial steroid response or recurrence and were treated successfully with CyberKnife (Accuray Inc., Sunnyvale, CA, USA).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Orbital inflammatory syndrome (OIS) or orbital pseudotumor is the most frequent cause ofan orbital mass.
📊
Key Findings & Data:Most cases are steroid responsive, but treatment of patients with refractoryOIS may also include radiotherapy.
💡
Conclusion & Impact:Presently described are 3 cases of orbital pseudotumorthat had a partial steroid response or recurrence and were treated successfully with CyberKnife (Accuray Inc., Sunnyvale, CA, USA).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Orbital inflammatory syndrome (OIS) or orbital pseudotumor is the most frequent cause ofan orbital mass. Most cases are steroid responsive, but treatment of patients with refractoryOIS may also include radiotherapy. Presently described are 3 cases of orbital pseudotumorthat had a partial steroid response or recurrence and were treated successfully with CyberKnife (Accuray Inc., Sunnyvale, CA, USA).

Özet

Orbital enflamatuvar sendrom veya orbital psödotümör orbital kitlelerin en sık nedenidir. Olguların çoğu steroid yanıtlıdır ancak tedaviye dirençli hastalar radyoterapi seçeneğine sahip olabilirler. Burada başarılı bir CyberKnife tedavisi yaklaşımı ile kısmi steroid cevabı veya nüks gösteren üç orbital psödotümör olgusu sunduk.

🔖

Cite This Article

IŞIK, N., YAPRAK, D. Ç., YAPRAK, G., KILIÇ, A. K., ŞEŞEOĞULLAR, Ö. O. (2022). Efficient Treatment of Resistant Orbital Pseudotumor with CyberKnife: Case Series and Short Review of Literature. Southern Clinics of Istanbul Eurasia, Cilt: 29 - Sayı: 3, 198–202. https://ajindex.com/articles/592905

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol 2006;34:239–44
  2. Shields JA, Bakewell B, Augsburger JJ, Flanagan JC. Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Arch Ophthalmol 1984;102:1606–11
  3. Szabo B, Szabo I, Crişan D, Stefănuţ C. Idiopathic orbital inflammatory pseudotumor: case report and review of the literature. Rom J Morphol Embryol 2011;52:927–30
  4. Ding ZX, Lip G, Chong V. Idiopathic orbital pseudotumour. Clin Radiol 2011;66:886–92
  5. Espinoza GM. Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep 2010;12:443–47
  6. Min HK, Lee YS, Yang SW, Lee J, Kwok SK, Ju JH, Kim WU, Park SH. Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor. Korean J Intern Med 2017 Oct 19 [Epub ahead of print], doi: 10.3904/kjim.2016.304
  7. Leo M, Maggi F, Dottore GR, Casini G, Mazzetti P, Pistello M, et al. Graves’ orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study. J Endocrinol Invest 2017;40:499–503
  8. Fernández-Codina A, Pinilla B, Pinal-Fernández I, López C, FraileRodríguez G, Fonseca-Aizpuru E, et al; Spanish Registry of IgG4 Related Disease (REERIGG4) investigators; Autoimmune Diseases Group (GEAS); Spanish Internal Medicine Society (SEMI). Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index. Joint Bone Spine 2018. pii: S1297- 319X(18)30017–4
  9. Flanders AE, Mafee MF, Rao VM, Choi KH. CT characteristics of orbital pseudotumors and other orbital inflammatory processes. J Comput Assist Tomogr 1989;13:40–7
  10. Clifton AG, Borgstein RL, Moseley IF, Kendall BE, Shaw PJ. Intracranial extension of orbital pseudotumour. Clin Radiol 1992;45:23–6
  11. Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol 2010;33:304–6
  12. Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, et al.Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 2007;91:1667–70
  13. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491–9
  14. Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA,